Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
From new and noteworthy spots to the classics that have stood the test of time, here are the top 100 bars in Miami of 2025. Fort Lauderdale’s Blue Martini bar has filed for bankruptcy at the Galleria ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results